|
rs1292037
|
|
Secondary malignant neoplasm of lymph node
|
|
0.010 |
GeneticVariation
|
BEFREE |
The influencing factors of resistance to cisplatin plus paclitaxel included maximum lesion diameter, tumor stage, lymph node metastasis and rs1292037 (odds ratio [OR] = 14.047, 95% CI = 5.694-34.653; OR = 5.873, 95% CI = 3.104-11.110; OR = 3.574, 95% CI = 1.554-8.216; OR = 2.449, 95% CI = 1.052-5.705).
|
30447706 |
2018 |
|
rs1292037
|
|
Cervix carcinoma
|
|
0.010 |
GeneticVariation
|
BEFREE |
In addition to that, the G allele at rs1292037 (A > G) locus increases the risk of preoperative chemoresistance to cisplatin plus paclitaxel and is a poor prognostic factor for patients with CC.
|
30447706 |
2018 |
|
rs1292037
|
|
cervical cancer
|
|
0.010 |
GeneticVariation
|
BEFREE |
In addition to that, the G allele at rs1292037 (A > G) locus increases the risk of preoperative chemoresistance to cisplatin plus paclitaxel and is a poor prognostic factor for patients with CC.
|
30447706 |
2018 |
|
rs1292037
|
|
Neoplasms
|
|
0.010 |
GeneticVariation
|
BEFREE |
The risk factors of prognosis included rs1292037 (A > G) locus, tumor stage, maximum lesion diameter and lymph node metastasis (hazard ratio [HR] = 1.819, 95% CI = 1.127-2.935; HR = 1.504, 95% CI = 1.070-2.114; HR = 1.671, 95% CI = 1.038-2.689; HR = 3.043, 95% CI = 1.783-5.193).
|
30447706 |
2018 |
|
rs1292037
|
|
Malignant tumor of cervix
|
|
0.010 |
GeneticVariation
|
BEFREE |
In addition to that, the G allele at rs1292037 (A > G) locus increases the risk of preoperative chemoresistance to cisplatin plus paclitaxel and is a poor prognostic factor for patients with CC.
|
30447706 |
2018 |
|
rs1292037
|
|
Ischemic stroke
|
|
0.010 |
GeneticVariation
|
BEFREE |
We investigated whether three common microRNA polymorphisms (miR-21T>C [rs1292037], miR-126G>A [rs4636297] and miR-605T>C [rs2043556]) were associated with ischemic stroke (IS) risk in a Chinese population.
|
29221163 |
2017 |
|
rs13137
|
|
Sepsis
|
|
0.010 |
GeneticVariation
|
BEFREE |
The T allele of the miR-21 SNP rs13137 and the T allele of the miR-145 SNP rs353291 (OR = 0.685, 95% CI = 0.566-0.820, P < .001) were found to be a protective factor for sepsis (OR = 0.755, 95% CI = 0.632-0.896, P < .001).
|
31415369 |
2019 |
|
rs13137
|
|
Septicemia
|
|
0.010 |
GeneticVariation
|
BEFREE |
The T allele of the miR-21 SNP rs13137 and the T allele of the miR-145 SNP rs353291 (OR = 0.685, 95% CI = 0.566-0.820, P < .001) were found to be a protective factor for sepsis (OR = 0.755, 95% CI = 0.632-0.896, P < .001).
|
31415369 |
2019 |
|
rs13137
|
|
Malignant tumor of cervix
|
|
0.010 |
GeneticVariation
|
BEFREE |
We investigated correlations of miR-21 gene polymorphisms including rs1292037 (A > G) and rs13137 (A > T) with the chemosensitivity to cisplatin plus paclitaxel, and prognosis before cervical cancer (CC) surgery, which may provide a novel target for prevention and treatment of CC.
|
30447706 |
2018 |
|
rs13137
|
|
cervical cancer
|
|
0.010 |
GeneticVariation
|
BEFREE |
We investigated correlations of miR-21 gene polymorphisms including rs1292037 (A > G) and rs13137 (A > T) with the chemosensitivity to cisplatin plus paclitaxel, and prognosis before cervical cancer (CC) surgery, which may provide a novel target for prevention and treatment of CC.
|
30447706 |
2018 |
|
rs13137
|
|
Cervix carcinoma
|
|
0.010 |
GeneticVariation
|
BEFREE |
We investigated correlations of miR-21 gene polymorphisms including rs1292037 (A > G) and rs13137 (A > T) with the chemosensitivity to cisplatin plus paclitaxel, and prognosis before cervical cancer (CC) surgery, which may provide a novel target for prevention and treatment of CC.
|
30447706 |
2018 |